Arkolith/Insider Trading/INDP/Form 4

Lazar David E.

DirectorIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Mar 24, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2026Sell(S)197K——103K
Mar 23, 2026Sell(S)700K——0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-26-000788) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML